Trevena (TRVN) - Profit After Payment of Taxes

Corporate emblem and logo of trevena.com (TRVN)

Is it worth investing in Trevena, Inc. (TRVN), a name associated with safe analgesics without opioid risks? This chart provided by the GURU.Markets platform illustrates the company's financial performance, which holds current significance 0.00. The business relies on external manufacturers and contract research to conserve capital; however, the slow clinical implementation of drugs creates financial pressure that necessitates cost optimization.

TRVN (Trevena) Net Profit history from 07/04/2022 to 10/19/2024

Financial and market metric breakdowns for Trevena (TRVN)

- stock value and consensus price forecast:
Market Price Trevena Inc|TRVN - Consensus Target
- market capitalization indicators:
Market Value Trevena Inc|TRVN - Total Company Value
- balance sheet net asset value indicators:
Accounting Value of a Share Trevena|TRVN - Book Capitalization|Market-to-Book Ratio trevena.com|TRVN - Cumulative Company Assets
- debt and liquidity details:
Debt to Equity Trevena, Inc.|TRVN - Long-Term Debt to Capital|Current Liabilities to Capital Trevena Inc.|TRVN - Company Debts|Debt to Book Value Ratio Trevena Inc|TRVN - Company Long-Term Debts|Company Short-Term Debts Trevena|Intermediate Coverage Ratio trevena.com
- net income and valuation multiples indicators:
TRVN - Net Profit
Basic company analysis:Trevena Inc
Finished products of Trevena, Inc.

The stability of Trevena, Inc. (TRVN) is determined by the effectiveness of international scientific collaborations, which may be destabilized by geopolitical risks in the field of biomaterials and patents. Tracking daily net profit allows for the filtering of market noise by measuring the real profitability of the business; therefore, analyzing the company's net profit trend helps investors identify the fundamental strength of the asset even during periods of cyclical drawdowns or mass sell-offs.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Net Income NBIX|RGC (regencellbioscience.com) - Profit After Payment of Taxes|Company Net Income Axsome Therapeutics, Inc. (AXSM)|ACAD (ACADIA Pharma) - Final Profit|Net Profit XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Company Net Income|SUPN: Net Income|CPRX: Company Net Income|DNLI: Net Profit|Company Net Income Harmony Biosciences Inc (HRMY)|Company Net Income Biohaven Pharmaceutical|Company Profit AMLX (Amylyx Corp)|Net Profit TRVI|Net Profit praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|Prothena Biosciences - Net Profit|Net Financial Result Alector, Inc. ALEC|Annexon, Inc. (ANNX) - Company Net Income|Company Profit OMER|NGNE (Neurogene) - Net Profit|Net Income AC Immune S.A. (ACIU)|Net Income VYGR (Voyager Pharma)|Net Financial Result Neumora Corp|Scilex Holding Company - Net Income|Profit After Payment of Taxes TVGN (tevogen.com)|ACOG - Company Net Income|Final Profit CGTX (cogrx.com)|IKT (Inhibikase) - Net Income|SAVA (Cassava Pharma) - Company Net Income|Company Net Income Assertio Holdings|Company Profit COYA (Coya)|Company Net Income Vistagen Therapeutics (VTGN)|ovidrx.com - Company Profit|Net Profit ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Company Net Income|ATHE: Net Income|CLNN - Net Profit|pepgen.com (PEPG) - Company Net Income|jupiterneurosciences.com - Final Profit|Company Net Income Relmada|Company Net Income Annovis Bio Corporation ANVS|Net Income GRCE (Grace Therapeutics, Inc.)|Profit After Payment of Taxes AIFF|Company Net Income Klotho Neurosciences KLTO|Final Profit NRSN|Reviva Pharmaceuticals Holdings - Net Profit|Company Net Income MetaVia Inc|NRXS (NeurAxis, Inc.) - Net Income|HSDT (Helius Medical Technologies) - Company Net Income|PASG (Passage Bio Inc.) - Net Profit|Company Net Income Neuphoria NEUP|Company Net Income Minerva Neurosciences Corp (NERV)|Athira Pharma Corp - Company Profit|Net Profit ADXN (Addex Therapeutics)|Net Profit Alzamend Neuro Inc. ALZN|CYCN: Net Income|Final Profit PTIX (Protagenic Therapeutics)|KTTA: Net Profit|CRGT - Net Financial Result|Company Net Income Avenue Therapeutics|Company Profit BCLI (brainstorm-cell.com)|Net Profit CARA|Net Income Chromocell Therapeutics Corp CHRO|Eliem Therapeutics Inc. - Net Income|Net Financial Result Intra-Cellular Therapies Inc. (ITCI)|LBPH: Net Income|marinuspharma.com - Profit After Payment of Taxes|NKGen Biotech (NKGN) - Company Net Income|NeuroBo Pharmaceuticals Inc - Final Profit|Net Income SAGE|Company Net Income SNPX|Company Net Income Vigil Neuroscience (VIGL)|Anew Medical Inc. - Company Profit|Company Net Income Cerevel Therapeutics, Inc. CERE